BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $78,000 | -38.6% | 74,500 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $127,000 | -69.8% | 74,500 | -40.2% | 0.00% | -60.0% |
| Q1 2019 | $420,000 | +15.4% | 124,500 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $364,000 | -60.5% | 124,500 | -16.7% | 0.01% | -44.4% |
| Q3 2018 | $921,000 | +152.3% | 149,500 | +202.0% | 0.01% | +125.0% |
| Q2 2018 | $365,000 | +12.3% | 49,500 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $325,000 | – | 49,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |